Get the Stockscreener App
9.05
0.11%
-0.010
After Hours:
9.05
Avadel Pharmaceuticals Plc Stock (AVDL) Forecast
The Avadel Pharmaceuticals Plc (AVDL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $75.93, representing a +739.03% increase from the current price of $9.05. The highest analyst price target is $77.70, and the lowest is $74.16.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVDL Price Target
Average 95.80
(+958.57% Upside)
Is Avadel Pharmaceuticals Plc (AVDL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.47 | Neutral |
| STOCH(9,6) | 55.55 | Neutral |
| STOCHRSI(14) | 25.92 | Neutral |
| MACD(12,26) | 0.1923 | Sell |
| ADX(14) | 22.33 | Neutral |
| William %R | -53.93 | Neutral |
| CCI(14) | -12.39 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.042
Buy
|
9.0705
Sell
|
| MA20 |
9.0583
Sell
|
8.9513
Buy
|
| MA50 |
8.4015
Buy
|
8.678
Buy
|
| MA100 |
8.3903
Buy
|
9.0351
Buy
|
| MA200 |
10.72
Sell
|
10.45
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, AVDL could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on AVDL, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 53.47 indicates that AVDL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.55 indicates that AVDL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.92 indicates that AVDL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.33 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -12.39 indicates that AVDL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term AVDL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Avadel Pharmaceuticals Plc financial reports and earnings history, Avadel Pharmaceuticals Plc (AVDL) stock could reach $46.18 by 2030, $647.59 by 2040 and $791.63 by 2050. See the projected annual prices until 2050 of the Avadel Pharmaceuticals Plc stock below:
- Avadel Pharmaceuticals Plc (AVDL) is expected to reach an average price of $493.15 in 2035, with a high prediction of $493.48 and a low estimate of $484.72. This indicates an $5,349% rise from the last recorded price of $9.05.
- Avadel Pharmaceuticals Plc (AVDL) stock is projected to chart a bullish course in 2040, with an average price target of $647.22, representing an $7,052% surge from its current level. The forecast ranges from a conservative $637.37 to a sky-high $647.59.
- Our analysts predict Avadel Pharmaceuticals Plc (AVDL) to jump 8,122% by 2045, soaring from $732.88 to an average price of $744.06, potentially reaching $746.90. While $732.88 is the low estimate, the potential upside is significant.
- Avadel Pharmaceuticals Plc (AVDL) stock is expected to climb by 2050, reaching an average of $791.05, a $8,641% jump from its current level. However, a wide range of estimates exists, with high and low targets of $791.63 and $778.77, respectively, highlighting the market's uncertainty.
Avadel Pharmaceuticals Plc Stock (AVDL) Year by Year Forecast
Avadel Pharmaceuticals Plc Stock (AVDL) Price Forecast for 2025
Avadel Pharmaceuticals Plc Stock (AVDL) is expected to reach an average price of $73.61 in 2025, with a high prediction of $95.23 and a low estimate of $51.99. This indicates an +713.39% rise from the last recorded price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $74.83 | $74.16 | $77.70 | +726.81% |
| July, 2025 | $80.43 | $75.24 | $80.63 | +788.69% |
| August, 2025 | $82.29 | $79.66 | $82.47 | +809.23% |
| September, 2025 | $86.04 | $82.63 | $86.55 | +850.71% |
| October, 2025 | $88.29 | $86.14 | $89.17 | +875.63% |
| November, 2025 | $90.29 | $87.93 | $90.90 | +897.67% |
| December, 2025 | $94.49 | $90.99 | $95.23 | +944.13% |
Avadel Pharmaceuticals Plc Stock (AVDL) Price Forecast for 2026
The predicted value for Avadel Pharmaceuticals Plc (AVDL) in 2026 is set at an average of $119.60. Estimates vary from a peak of $143.95 to a trough of $95.26, indicating an +1,222% surge from the present price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $100.29 | $95.26 | $100.37 | +1,008% |
| February, 2026 | $103.35 | $100.53 | $104.38 | +1,042% |
| March, 2026 | $106.20 | $103.75 | $106.53 | +1,073% |
| April, 2026 | $112.86 | $106.92 | $113.12 | +1,147% |
| May, 2026 | $116.27 | $112.44 | $117.44 | +1,185% |
| June, 2026 | $119.26 | $116.35 | $119.68 | +1,218% |
| July, 2026 | $122.36 | $119.53 | $123.26 | +1,252% |
| August, 2026 | $125.73 | $122.65 | $126.20 | +1,289% |
| September, 2026 | $129.26 | $126.25 | $129.62 | +1,328% |
| October, 2026 | $133.47 | $129.47 | $133.77 | +1,375% |
| November, 2026 | $137.27 | $133.92 | $137.37 | +1,417% |
| December, 2026 | $142.98 | $137.91 | $143.95 | +1,480% |
Avadel Pharmaceuticals Plc Stock (AVDL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Avadel Pharmaceuticals Plc (AVDL) is $164.11, with a high forecast of $184.55 and a low forecast of $143.66. This indicates an +1,713% increase from the last price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $144.72 | $143.66 | $146.21 | +1,499% |
| February, 2027 | $149.70 | $145.24 | $151.51 | +1,554% |
| March, 2027 | $151.64 | $150.17 | $152.33 | +1,576% |
| April, 2027 | $153.95 | $152.16 | $155.22 | +1,601% |
| May, 2027 | $156.94 | $153.83 | $157.30 | +1,634% |
| June, 2027 | $162.55 | $157.55 | $163.30 | +1,696% |
| July, 2027 | $165.25 | $162.90 | $165.62 | +1,726% |
| August, 2027 | $168.36 | $166.06 | $168.64 | +1,760% |
| September, 2027 | $168.49 | $166.84 | $169.91 | +1,762% |
| October, 2027 | $171.69 | $168.91 | $171.85 | +1,797% |
| November, 2027 | $177.08 | $172.47 | $177.39 | +1,857% |
| December, 2027 | $183.85 | $177.68 | $184.55 | +1,932% |
Avadel Pharmaceuticals Plc Stock (AVDL) Price Forecast for 2028
In 2028, Avadel Pharmaceuticals Plc (AVDL) is projected to reach an average price of $210.69, with a high projection of $237.18 and a low estimate of $184.20. This indicates an +2,228% rise from the last price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $186.91 | $184.20 | $187.11 | +1,965% |
| February, 2028 | $188.66 | $186.83 | $188.98 | +1,985% |
| March, 2028 | $194.45 | $189.34 | $194.56 | +2,049% |
| April, 2028 | $199.21 | $194.40 | $199.70 | +2,101% |
| May, 2028 | $202.41 | $199.74 | $203.25 | +2,137% |
| June, 2028 | $205.71 | $202.56 | $205.86 | +2,173% |
| July, 2028 | $209.91 | $206.44 | $210.03 | +2,219% |
| August, 2028 | $215.06 | $210.60 | $216.48 | +2,276% |
| September, 2028 | $218.29 | $215.80 | $219.44 | +2,312% |
| October, 2028 | $228.05 | $219.06 | $228.87 | +2,420% |
| November, 2028 | $231.39 | $228.04 | $231.79 | +2,457% |
| December, 2028 | $237.14 | $231.88 | $237.18 | +2,520% |
Avadel Pharmaceuticals Plc Stock (AVDL) Price Forecast for 2029
The 2029 price forecast for Avadel Pharmaceuticals Plc Stock (AVDL) is $158.97 on average, with a high prediction of $282.59 and a low estimate of $35.36. This represents an +1,657% increase from the previous price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $238.96 | $236.04 | $240.03 | +2,540% |
| February, 2029 | $242.13 | $238.49 | $242.40 | +2,575% |
| March, 2029 | $243.86 | $242.54 | $244.89 | +2,595% |
| April, 2029 | $245.48 | $243.17 | $246.31 | +2,612% |
| May, 2029 | $249.82 | $245.88 | $251.95 | +2,660% |
| June, 2029 | $255.05 | $250.25 | $255.10 | +2,718% |
| July, 2029 | $260.01 | $255.70 | $260.65 | +2,773% |
| August, 2029 | $264.48 | $260.61 | $265.05 | +2,822% |
| September, 2029 | $266.08 | $265.18 | $267.41 | +2,840% |
| October, 2029 | $274.88 | $266.73 | $275.10 | +2,937% |
| November, 2029 | $278.36 | $274.70 | $279.88 | +2,976% |
| December, 2029 | $35.43 | $35.36 | $282.59 | +291.54% |
Avadel Pharmaceuticals Plc Stock (AVDL) Price Forecast for 2030
Avadel Pharmaceuticals Plc Stock (AVDL) is expected to reach an average price of $83.57 in 2030, with a high forecast of $130.08 and a low forecast of $37.06. This signifies an +823.41% surge from the last price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $45.88 | $37.06 | $46.18 | +407.00% |
| February, 2030 | $51.62 | $46.94 | $51.96 | +470.36% |
| March, 2030 | $58.33 | $53.23 | $58.58 | +544.48% |
| April, 2030 | $65.31 | $59.76 | $65.69 | +621.70% |
| May, 2030 | $75.43 | $66.71 | $75.52 | +733.53% |
| June, 2030 | $82.15 | $76.69 | $82.28 | +807.74% |
| July, 2030 | $92.29 | $83.76 | $92.59 | +919.81% |
| August, 2030 | $99.19 | $93.82 | $100.12 | +996.04% |
| September, 2030 | $106.78 | $100.80 | $107.05 | +1,080% |
| October, 2030 | $115.35 | $108.21 | $116.11 | +1,175% |
| November, 2030 | $120.80 | $116.79 | $124.48 | +1,235% |
| December, 2030 | $129.70 | $120.77 | $130.08 | +1,333% |
0.12%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):